Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xia Feng

Showing results (481-490 of 487) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 487 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 28, 2025
Mesenchymal Stromal Cells Play an Analgesic Role Through a Npy2r Sensory Neuron-Mediated Lung-to-Brain AxisJing Huang, Taihe Zhou, Yueming Sun, et al.
United European Gastroenterology Journal|May 16, 2024
Optical enhancement mode 2 improves the detection rate of gastric neoplastic lesion in high-risk populations: A multicenter randomized controlled clinical studyWei An, Qi Wu, Xiao-Ju Su, et al.
Nature Communications|October 7, 2020
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19Yue Gao, Guang-Yao Cai, Wei Fang, et al.
Pharmacological Research|October 29, 2021
Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019Zhi-Yu Li, Zhi-Jun Xie, Hai-Chang Li, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
Pageof 49

Showing results (481-490 of 487) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 487 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 28, 2025
Mesenchymal Stromal Cells Play an Analgesic Role Through a Npy2r Sensory Neuron-Mediated Lung-to-Brain AxisJing Huang, Taihe Zhou, Yueming Sun, et al.
United European Gastroenterology Journal|May 16, 2024
Optical enhancement mode 2 improves the detection rate of gastric neoplastic lesion in high-risk populations: A multicenter randomized controlled clinical studyWei An, Qi Wu, Xiao-Ju Su, et al.
Nature Communications|October 7, 2020
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19Yue Gao, Guang-Yao Cai, Wei Fang, et al.
Pharmacological Research|October 29, 2021
Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019Zhi-Yu Li, Zhi-Jun Xie, Hai-Chang Li, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
Pageof 49